Chardan Details?
Just curious to learn more about Chardan. Don't know much about them, but they seem like a sizeable bank.
Do they take SA's, how is comp, exit opps, rep?
Thank you!
Trending Content - Investment Banking Forum
| +267 | Why UBS Is the Worst Place to Start Your IB Career | 40 | 2d |
| +219 | UBS 2nd Year Analyst Q&A (2026) | 41 | 1d |
| +102 | What's your craziest "hardo" story? | 18 | 4h |
| +73 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 11 | 3h |
| +53 | Wolf of Wall Street vs. Reality: Anyone else feel scammed by the movies? | 19 | 18h |
| +50 | Suspended for a Year | 21 | 20h |
| +49 | Elite Boutique interview questions | 17 | 2d |
| +37 | so confused about 28 SA timeline | 30 | 13h |
| +34 | Lincoln International Return Offers | 9 | 1h |
| +33 | Rate my non-target resume | 19 | 7h |
Career Resources
Bump
bump
Chardan is a SPAC powerhouse that has had an absolutely killer past several years.
With a lot of SPACs not successfully de-SPACing anymore and returning capital to investors, the sponsors got burned because they have paid a bunch of fees to a banker like Chardan, EarlyBird, or a BB bank’s ECM team. This is what kills the deal flow.
SPACs are the red-headed stepchild of Wall Street right now, but if you love the product, there will always be more SPACs.
Feel free to ask any follow-ons about the product.
Do you have any info on their equity research team? Seems like this is still connected to their SPAC practice but not exactly sure how.
Is it just SPAC sponsors paying for coverage?
They don’t cover a ton of stocks. Most of the stocks are biotech, which makes sense given that it was a popular de-SPAC target market. Most of the biotech stocks were actually never SPACs; I think it’s just a core competency they had and felt they understood.
Then there’s the other tech coverage, and that list reads like a who’s who of SPACs. BMTX, PLBY, KITT, PRST, PET, etc. Giving coverage of the stock after the fact supports the IPO activity of the firm and is good karma.
I think they have a small, but non-SPAC biotech arm which evolved from their de-SPAC activities, and they cover some of their own cooking on the SPAC side as goodwill.
Very helpful, do you have any color on culture, WLB, bonus figures, etc.
Sed eius nostrum et nostrum. Inventore et ut eum quae quia quos excepturi. Nesciunt ea nam molestiae id animi est.
Neque assumenda tenetur voluptas dolore animi eaque tempora. Quasi facilis quod maiores nisi est.
Fuga et consectetur nobis mollitia accusamus. Magnam ea dolores quaerat sint id. Ipsum corrupti minus aliquid sapiente asperiores qui. Omnis corporis totam quis ullam odit. Ullam tempore possimus sapiente quia quas dolore iste. Voluptatem autem veritatis non exercitationem. Ut laboriosam officia voluptatem quasi veritatis voluptatum.
Eum itaque sequi aut fuga assumenda recusandae et. Consequatur commodi recusandae qui rerum. Aut voluptatem fugiat dolorem. Aperiam aut occaecati cupiditate explicabo. Exercitationem accusantium et aliquid ea voluptas sed. Laborum vel quas dolor optio et. Animi sequi non placeat esse corrupti.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...